When Novo Nordisk reports earnings Wednesday morning, investors will be seeking reassurance that they haven’t overestimated ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to ..

People who have obesity regularly report medical providers are rude or dismissive toward them, research shows, which can lead ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that ...

New drug approach could underpin future weight loss therapies, study indicates. ScienceDaily . Retrieved November 1, 2024 from www.sciencedaily.com / releases / 2024 / 10 / 241010124907.htm ...

A Dallas-based producer of men’s health and wellness products recently launched two weight-loss tablets marketed as alternatives to drugs like ... was founded in 2021 and went public in March ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new ...

Diabetes and weight loss drugs like Mounjaro and Ozempic may also help patients suffering from addiction, according to a new study. In the study, published Thursday in the scientific journal ...

Semaglutide is a relatively new drug ... In 2021, the US Food and Drug Administration (FDA) approved a higher dose of Semaglutide, marketed as Wegovy, specifically for chronic weight management ...